GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guangdong VTR Bio-Tech Co Ltd (SZSE:300381) » Definitions » 3-Year EBITDA Growth Rate

Guangdong VTR Bio-Tech Co (SZSE:300381) 3-Year EBITDA Growth Rate : -36.50% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Guangdong VTR Bio-Tech Co 3-Year EBITDA Growth Rate?

Guangdong VTR Bio-Tech Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.04.

During the past 12 months, Guangdong VTR Bio-Tech Co's average EBITDA Per Share Growth Rate was -71.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -36.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -25.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Guangdong VTR Bio-Tech Co was 49.80% per year. The lowest was -37.40% per year. And the median was 17.95% per year.


Competitive Comparison of Guangdong VTR Bio-Tech Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Guangdong VTR Bio-Tech Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong VTR Bio-Tech Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guangdong VTR Bio-Tech Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Guangdong VTR Bio-Tech Co's 3-Year EBITDA Growth Rate falls into.



Guangdong VTR Bio-Tech Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Guangdong VTR Bio-Tech Co  (SZSE:300381) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Guangdong VTR Bio-Tech Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Guangdong VTR Bio-Tech Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong VTR Bio-Tech Co (SZSE:300381) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Pingbei 1st Road, Nanping Science and Technology Industrial Park, Guangdong Province, Zhuhai, CHN, 519060
Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme, and others. It sells its products in China, and also exports it to various other countries.

Guangdong VTR Bio-Tech Co (SZSE:300381) Headlines

No Headlines